MedicarePartD.guide

A non-government resource built from CMS public data

Breo Ellipta on SilverScript Choice (S5601-054)

fluticasone/vilanterol

Covered.

Tier 3 (preferred brand). Quantity limit of 60 per 30 days.

$72.14
Patient pays / month, after deductible
$400.76
Patient pays / month, before the $615.00 deductible
$216.41
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

BREO ELLIPTA 50/25 ug Powder at a preferred retail pharmacy, from the plan's negotiated price of $400.76 for a month. Other covered strengths are listed below.

All 3 covered strengths and forms
FormTierPatient pays / monthLimits
BREO ELLIPTA 100/25 ug Powder3$72.2160 per 30 days
BREO ELLIPTA 200/25 ug Powder3$72.2260 per 30 days
BREO ELLIPTA 50/25 ug Powder3$72.1460 per 30 days

Other COPD and asthma inhalers on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-054